ARPIs for dummies! Plus the Jiffy Stent

GU Cast | Urology Podcast

Inhoud geleverd door Professor Declan Murphy & Dr Renu Eapen, Professor Declan Murphy, and Dr Renu Eapen. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Professor Declan Murphy & Dr Renu Eapen, Professor Declan Murphy, and Dr Renu Eapen of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

10M ago 34:16

MP3•Thuis aflevering

It has becoming a familiar refrain around the world , and is certainly good news for the prostate cancer community! This week, another androgen receptor pathway inhibitor (ARPI) became reimbursed for men with hormone-sensitive metastatic prostate cancer (mHSPC) in Australia. Darolutamide is already available for men with non-metastatic castration-resistant prostate cancer, and is now also available for men with mHSPC in combination with androgen deprivation therapy and chemotherapy. Therefore we continue on our mission at GU Cast to educate ourselves about the use of ARPIs in mHSPC. And yes, even simple urologists like us can get up to speed with these drugs!
Declan and Renu are joined by fellow Urologist Associate Professor Joseph Ischia, one of our favourite prostate cancer experts. And a great podcaster himself! Check out the back catalogue of "Talking Urology" using the links below.
Plus what is a "jiffy stent"??? \
This Themed Podcast is supported by Bayer, Silver Partners of GU Cast.
Even better on our YouTube channel
Link:
https://www.talkingurology.com.au/

150 afleveringen

#Science #Fitness #Medicine #Dr Renu Eapen #Professor Declan Murphy #Urology #Prostate Cancer #Kidney Cancer #Testis Cancer #Penile Cancer #Gu Oncology #Cancer #Podcasting Education #Professor Declan Murphy And Dr Renu Eapen